Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 500 entries
View as:

Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133)

Phase: N/A Priority: Normal
NCT ID: NCT00338260 Org: User:
Start: 06/30/95 End: 11/30/01 Due: 11/30/02

A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7)

Phase: N/A Priority: Normal
NCT ID: NCT01001234 Org: User:
Start: 11/30/09 End: 04/21/11 Due: 04/21/12

An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)

Phase: N/A Priority: Normal
NCT ID: NCT03867110 Org: User:
Start: 03/06/00 End: 07/27/01 Due: 07/27/02

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)

Phase: N/A Priority: Normal
NCT ID: NCT00702338 Org: User:
Start: 05/15/08 End: 12/15/08 Due: 12/15/09

Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)

Phase: N/A Priority: Normal
NCT ID: NCT02668783 Org: User:
Start: 02/11/16 End: 09/07/16 Due: 09/07/17

Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00862251 Org: User:
Start: 04/30/09 End: 03/31/11 Due: 03/31/12

A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)

Phase: N/A Priority: Normal
NCT ID: NCT01709331 Org: User:
Start: 02/11/13 End: 04/08/15 Due: 04/08/16

An Observational Follow-Up Study of the Incidence of Cancer and Mortality in Patients From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Trial (MK-0653A-043-10)

Phase: N/A Priority: Normal
NCT ID: NCT01077830 Org: User:
Start: 03/31/10 End: 04/30/13 Due: 04/30/14

A Trial in Healthy Female Subjects to Compare the Pharmacokinetics of Ethinyl Estradiol of NuvaRing®, a Contraceptive Patch (EVRA(TM)) and an Oral Contraceptive (Microgynon® 30) (Study 34237 (P06650)) (COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT01044056 Org: User:
Start: 03/31/04 End: 06/30/04 Due: 06/30/05

Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive

Phase: N/A Priority: Normal
NCT ID: NCT05264506 Org: User:
Start: 02/17/22 End: 01/26/24 Due: 01/26/25

Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771)

Phase: N/A Priority: Normal
NCT ID: NCT00145496 Org: User:
Start: 12/31/04 End: 12/31/08 Due: 12/31/09

Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)

Phase: N/A Priority: Normal
NCT ID: NCT00394355 Org: User:
Start: 09/30/06 End: 10/31/09 Due: 10/31/10

Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)

Phase: N/A Priority: Normal
NCT ID: NCT00943683 Org: User:
Start: 08/31/00 End: 02/28/01 Due: 02/28/02

An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)

Phase: N/A Priority: Normal
NCT ID: NCT01498770 Org: User:
Start: 04/01/13 End: 12/21/17 Due: 12/21/18

Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)

Phase: N/A Priority: Normal
NCT ID: NCT00242489 Org: User:
Start: 06/30/98 End: 07/31/02 Due: 07/31/03

A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)

Phase: N/A Priority: Normal
NCT ID: NCT01709318 Org: User:
Start: 12/12/12 End: 10/22/13 Due: 10/22/14

Tibolone Endometrium Study (Study 32972)(P06470)

Phase: N/A Priority: Normal
NCT ID: NCT00745108 Org: User:
Start: 10/01/01 End: 07/21/05 Due: 07/21/06

Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019)

Phase: N/A Priority: Normal
NCT ID: NCT03885921 Org: User:
Start: 10/25/00 End: 07/08/03 Due: 07/08/04

MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029)

Phase: N/A Priority: Normal
NCT ID: NCT00897104 Org: User:
Start: 08/31/95 End: 09/30/96 Due: 09/30/97

An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria (Study P02540)

Phase: N/A Priority: Normal
NCT ID: NCT00795522 Org: User:
Start: 07/31/03 End: 03/31/05 Due: 03/31/06

Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00319449 Org: User:
Start: 09/30/05 End: 10/31/06 Due: 10/31/07

MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)

Phase: N/A Priority: Normal
NCT ID: NCT01307046 Org: User:
Start: 03/29/11 End: 02/07/12 Due: 02/07/13

Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)

Phase: N/A Priority: Normal
NCT ID: NCT00092209 Org: User:
Start: 04/30/02 End: 11/30/02 Due: 11/30/03

Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057)

Phase: N/A Priority: Normal
NCT ID: NCT00403793 Org: User:
Start: 10/31/03 End: 12/31/06 Due: 12/31/07

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)

Phase: N/A Priority: Normal
NCT ID: NCT00702520 Org: User:
Start: 04/01/06 End: 01/15/08 Due: 01/15/09